G1 Therapeutics Gross Margin 2016-2024 | GTHX
Current and historical gross margin for G1 Therapeutics (GTHX) over the last 10 years. The current gross profit margin for G1 Therapeutics as of June 30, 2024 is %.
| Gross Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Gross Profit | Gross Margin |
| 2024-06-30 | $0.06B | $0.05B | 89.66% |
| 2024-03-31 | $0.08B | $0.08B | 92.77% |
| 2023-12-31 | $0.08B | $0.08B | 91.46% |
| 2023-09-30 | $0.08B | $0.07B | 90.91% |
| 2023-06-30 | $0.09B | $0.08B | 93.26% |
| 2023-03-31 | $0.06B | $0.05B | 89.66% |
| 2022-12-31 | $0.05B | $0.05B | 90.38% |
| 2022-09-30 | $0.05B | $0.04B | 89.58% |
| 2022-06-30 | $0.03B | $0.03B | 86.21% |
| 2022-03-31 | $0.03B | $0.02B | 84.00% |
| 2021-12-31 | $0.03B | $0.03B | 90.63% |
| 2021-09-30 | $0.04B | $0.04B | 95.35% |
| 2021-06-30 | $0.07B | $0.06B | 98.46% |
| 2021-03-31 | $0.06B | $0.06B | 100.00% |
